We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

New Nanotechnology-Based Diagnostic System Detects COVID-19 Within 10 Seconds

By LabMedica International staff writers
Posted on 05 Jan 2021
Image: Diagnovir (Photo courtesy of Bilkent University)
Image: Diagnovir (Photo courtesy of Bilkent University)
A newly developed COVID-19 diagnostic system uses nanotechnology to provide results in 10 seconds with 99% accuracy.

A team of researchers from the Bilkent University (Ankara, Turkey) has developed an “in vitro” virus diagnosis system that can be used to detect the SARS-CoV-2 virus. The new nanotechnology-based diagnostic system, called Diagnovir, can detect the COVID-19 virus within 10 seconds with a swab taken from the mouth. It is an optically based diagnostic and identification system that changes the color of the glow in the presence of the virus, thus detecting viruses with high selectivity.

In this system, pathogens are detected within 10 seconds by dynamically receiving a fluorescent signal via a pathogen detection chip developed specifically for a biosensor device. After the sample is taken from the patient, it is mixed with a special solution, dropped on the pathogen detection chip, and if there is a pathogen in the environment by the biosensor device, the presence of pathogens with high accuracy is detected by taking the fluorescent signal.

Unlike the commonly used PCR tests, the system is not based on sample replication, but on detecting the presence or absence of the virus with advanced optical methods. In the system, optical and electronic modules that provide both precise virus detection and high selectivity in detection, as well as high-level biotechnology and material science knowledge are used. The system has shown 99% success in virus detection in pre-clinical studies conducted so far.

Related Links:
Bilkent University

Gold Member
Multiplex Genetic Analyzer
MassARRAY Dx Analyzer (Europe only)
Gold Member
Universal Transport Solution
Puritan®UniTranz-RT
New
Steam Sterilizer
Hi Vac II Line
New
Thyroid Test
Anti-Thyroid EIA Test

Channels

Clinical Chemistry

view channel
Image: Plasma pTau217 testing can predict future amyloid accumulation and cognitive decline in cognitively healthy older adults (photo courtesy of Shutterstock)

Blood Test Predicts Alzheimer Disease Risk Before Imaging Changes and Symptoms

Alzheimer's disease often advances silently for years, making timely risk stratification difficult in routine practice. Current approaches to detect pathology can involve lumbar puncture or positron emission... Read more

Industry

view channel
Image: Pathlight combines WGS and dPCR to identify and longitudinally track large‑scale genomic changes, known as structural variants (photo courtesy of SAGA Diagnositcs)

Foundation Medicine to Expand MRD Portfolio with Pathlight Platform

Foundation Medicine, Inc., an independent affiliate of Roche, announced plans to expand its monitoring portfolio with SAGA Diagnostics’ Pathlight, a personalized, tumor-informed molecular residual disease... Read more